MindMed Reports Third Quarter 2023 Financial Results and Business Highlights

02.11.2023 - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its financial results for the ...

Related Keywords

Switzerland ,Canada ,Canadian ,Lang Schwarz ,Company Annual Report On Form ,University Hospital Basel ,Company Quarterly Report On Form ,Medicine Mindmed Inc ,Nasdaq ,European College Of Neuropsychopharmacology ,Exchange Commission ,Recent Highlights ,Anticipated Upcoming Milestones ,Hamilton Anxiety Rating Scale ,Rating Scale ,Hospital Basel ,Annual European College ,Cash Equivalents ,Cash Used ,Annual Report ,Quarterly Report ,Note Regarding Forward Looking Statements ,Financial Condition ,Consolidated Statements ,Mind Medicine ,Mind Medicine Mindmed Chart ,Ind Medicine Mindmed Kurs ,Ind Medicine Mindmed Aktie ,